Anti-CGRP antibody galcanezumab modifies the function of the trigeminovascular nocisensor complex in the rat.

"Declarations Ethics approval and consent to participateAll experiments and procedures were carried out according to the guidelines of the Ethical Committee for Animal Care of the University of Szeged (approval ID: XIV./1800/2021 and XIV./2368/2023) and carried out in accordance with the Directive 2010/63/EU of the European Parliament. Consent for publicationNot applicable. Competing interestsThe first author (NF) performed this work for obtaining her PhD degree at the University of Szeged. The other authors declare no competing interest. Competing interests The first author (NF) performed this work for obtaining her PhD degree at the University of Szeged. The other authors declare no competing interest."

"Funding Open access funding provided by University of Szeged. The project was supported by the research grants K119597 project of the Hungarian National Research, Development and Innovation Office, the Alexander von Humboldt Foundation (Research Group Linkage Program between the Institutes of Physiology of the FAU Erlangen-Nürnberg and the University of Szeged) and the University of Szeged Open Access Fund Grant 6680 and EFOP-3.6.3-VEKOP-16–2017-00009."